Effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on blast progenitors from acute myeloblastic leukaemia patients.

Por Nara, N., Murohashi, I., Suzuki, T., Yamashita, Y., Maruyama, Y., Aoki, N., Tanikawa, S., Onozawa, Y.
Publicado em 1987

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

Por Doi, T, Ohtsu, A, Yoshino, T, Boku, N, Onozawa, Y, Fukutomi, A, Hironaka, S, Koizumi, W, Sasaki, T
Publicado em 2012

An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks i...

Por Murakami, H., Kurata, T., Onozawa, Y., Watanabe, J., Ono, A., Takahashi, T., Yamamoto, N., Fujisaka, Y., Kiyota, H., Hayashi, H., Tanaka, K., Nakagawa, K., Kuroda, S.
Publicado em 2014